D119N (p.Asp119Asn) variant of KRAS (GTPase KRas)
D119N (p.Asp119Asn) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Autoimmune lymphoproliferative syndrome type 4; Acute myeloid leukemia; Noonan s. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes experimental measurements, published literature, and structural context.
D119N (p.Asp119Asn) variant details
- p.Asp119Asn
- rs730880471
- ClinGen CA296084
- cosmic curated COSV55546
- ClinVar RCV000157937
- Likely pathogenic
- Autoimmune lymphoproliferative syndrome type 4; Acute myeloid leukemia; Noonan s
- Missense
- Variant Prioritization Score for Impact Estimate 0.863
- ESM-1b 1.00
- AlphaMissense 1.00
- MetaLR 0.97
- MetaSVM 1.06
- CADD 32.00
- PolyPhen-2 1.00
- ClinVar: Likely pathogenic (Autoimmune lymphoproliferative syndrome type 4; Acute myeloid le)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- KRAS abundance — LZTR1ko: score 0.334
- Cited in: CEBPA-Associated Familial Acute Myeloid Leukemia. (PMID 20963938)
- Cited in: NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. (PMID 22138009)